Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Argus Health
Citi
Covington
Teva
Johnson and Johnson
Chubb
Julphar
Chinese Patent Office
UBS

Generated: January 19, 2018

DrugPatentWatch Database Preview

IOPAMIDOL-250 Drug Profile

« Back to Dashboard

When do Iopamidol-250 patents expire, and when can generic versions of Iopamidol-250 launch?

Iopamidol-250 is a drug marketed by Cook Imaging, Fresenius Kabi Usa, and Hospira. and is included in five NDAs.

The generic ingredient in IOPAMIDOL-250 is iopamidol. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the iopamidol profile page.
Drug patent expirations by year for IOPAMIDOL-250
Medical Subject Heading (MeSH) Categories for IOPAMIDOL-250

US Patents and Regulatory Information for IOPAMIDOL-250

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cook Imaging IOPAMIDOL-250 iopamidol INJECTABLE;INJECTION 074881-002 Jul 28, 2000 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira IOPAMIDOL-250 iopamidol INJECTABLE;INJECTION 075005-001 Feb 24, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa IOPAMIDOL-250 iopamidol INJECTABLE;INJECTION 074679-001 Apr 2, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira IOPAMIDOL-250 iopamidol INJECTABLE;INJECTION 074898-002 Dec 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira IOPAMIDOL-250 IN PLASTIC CONTAINER iopamidol INJECTABLE;INJECTION 074636-002 Dec 30, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Novartis
Express Scripts
Accenture
Fuji
Daiichi Sankyo
Dow
Medtronic
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot